In line with these findings, the liver-specific overexpression of H19 results in impaired glucose homeostasis with hyperglycemia and insulin resistance, whereas a whole-body knockout of H19 in mice leads to improved insulin sensitivity and reduced insulin-dependent endogenous glucose production in the liver, associated with the reduced expression of gluconeogenic genes [85]. This evidence concerns the gene INS and Hyperglycemia.